These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7664214)

  • 1. Molecular biology of angiotensin II biosynthesis and receptors.
    Dzau VJ
    Can J Cardiol; 1995 Aug; 11 Suppl F():21F-26F. PubMed ID: 7664214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of angiotensin synthetic pathways and receptor subtypes: physiological and pharmacological implications.
    Dzau VJ; Sasamura H; Hein L
    J Hypertens Suppl; 1993 Apr; 11(3):S13-8. PubMed ID: 8315512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II receptors-antagonists, molecular biology, and signal transduction.
    Jagadeesh G
    Indian J Exp Biol; 1998 Dec; 36(12):1171-94. PubMed ID: 10093499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The physiological significance of the alternative pathways of angiotensin II production.
    Kramkowski K; Mogielnicki A; Buczko W
    J Physiol Pharmacol; 2006 Dec; 57(4):529-39. PubMed ID: 17229979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II receptor subtypes: characterization, signalling mechanisms, and possible physiological implications.
    Bottari SP; de Gasparo M; Steckelings UM; Levens NR
    Front Neuroendocrinol; 1993 Apr; 14(2):123-71. PubMed ID: 8486206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to explain the differences between renin angiotensin system modulators.
    Levy BI
    Am J Hypertens; 2005 Sep; 18(9 Pt 2):134S-141S. PubMed ID: 16125050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.
    Masaki H; Kurihara T; Yamaki A; Inomata N; Nozawa Y; Mori Y; Murasawa S; Kizima K; Maruyama K; Horiuchi M; Dzau VJ; Takahashi H; Iwasaka T; Inada M; Matsubara H
    J Clin Invest; 1998 Feb; 101(3):527-35. PubMed ID: 9449684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of losartan, the first angiotensin II receptor antagonist.
    Timmermans PB; Duncia JV; Carini DJ; Chiu AT; Wong PC; Wexler RR; Smith RD
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S3-18. PubMed ID: 8583479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in metabolic disorders: hypercholesterolaemia and diabetes].
    Strawn WB
    Drugs; 2002; 62 Spec No 1():31-41. PubMed ID: 12036387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renin-angiotensin system and its role in cardiovascular physiopathology and therapy].
    Castro-Chaves P; Leite-Moreira AF
    Rev Port Cardiol; 2004 May; 23 Suppl 2():II61-77. PubMed ID: 15222251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-mediated effects of angiotensin II on neurons.
    Sumners C; Raizada MK; Kang J; Lu D; Posner P
    Front Neuroendocrinol; 1994 Sep; 15(3):203-30. PubMed ID: 7859913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation and function of extrarenal angiotensin receptors.
    Wang DH; Elijovich F
    Cell Biochem Biophys; 1999; 31(1):1-17. PubMed ID: 10505665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases.
    Kim S; Iwao H
    Pharmacol Rev; 2000 Mar; 52(1):11-34. PubMed ID: 10699153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From converting enzyme inhibition to angiotensin II receptor blockade: new insight on angiotensin II receptor subtypes in the kidney.
    Wolf G; Neilson EG
    Exp Nephrol; 1996; 4 Suppl 1():8-19. PubMed ID: 9001892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of angiotensin II in modulating cardiac function: intracardiac effects and signal transduction pathways.
    Dostal DE; Hunt RA; Kule CE; Bhat GJ; Karoor V; McWhinney CD; Baker KM
    J Mol Cell Cardiol; 1997 Nov; 29(11):2893-902. PubMed ID: 9405164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of angiotensin-converting enzyme two-week inhibition on renal angiotensin II receptors and renal vascular reactivity in SHR.
    Haddad G; Garcia R
    J Mol Cell Cardiol; 1997 Feb; 29(2):813-22. PubMed ID: 9140837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal mechanisms of angiotensin II-induced hypertension.
    Granger JP; Schnackenberg CG
    Semin Nephrol; 2000 Sep; 20(5):417-25. PubMed ID: 11022893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin converting enzyme-independent angiotensin ii production by chymase is up-regulated in the ischemic kidney in renovascular hypertension.
    Sadjadi J; Kramer GL; Yu CH; Burress Welborn M; Chappell MC; Gregory Modrall J
    J Surg Res; 2005 Aug; 127(2):65-9. PubMed ID: 15869764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin receptor subtype 1 mediates angiotensin II enhancement of isoproterenol-induced cyclic AMP production in preglomerular microvascular smooth muscle cells.
    Inoue T; Mi Z; Gillespie DG; Dubey RK; Jackson EK
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1229-34. PubMed ID: 10027863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [AT1 angiotensin receptor inhibition as a new therapeutic possibility].
    Hunyady L; Nagy L
    Orv Hetil; 1997 Oct; 138(41):2583-90. PubMed ID: 9411327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.